Locations:
Search IconSearch
June 25, 2020/Cancer

The Future of Inguinal Lymph Node Dissection Is Robotic

A closer look at the innovative procedure

650×450-Inguinal-lymph-nodes_robotic-ports_20-URL-1830311

Penile cancer is rare — it accounts for less than 1% of cancers in men in the United States — but its burden is no less insidious. It begins at the penis and advanced cases tend to spread into the inguinal lymph nodes located either superficially or deep within the groin.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

An inguinal lymph node dissection, or lymphadenectomy, has been the standard of care to diagnose, treat and prevent the spread of penile cancer. The procedure has been associated with a high complication rate including flap necrosis and lymphedema. In response, urologists have worked to minimize complications. Greater efforts have been made to improve early detection and develop less invasive surgical techniques.

Jayram Krishnan, DO, MBA, a urologic oncologist in Cleveland Clinic’s Glickman Urological & Kidney Institute, advocates for a robotic approach to inguinal node dissection. “Anecdotally, we see a significant reduction in postoperative complication, paired with a faster recovery, enabling patients to return to their daily activities sooner,” he says.

Procedural details

Adherence is given to all principles of the open surgical approach, but the robot allows surgeons to utilize smaller incisions, sparing the saphenous vein and limiting the area of dissection to superior-medial to the saphenofemoral junction — not performing a sartorious flap. Thus, this technique mitigates many of the risks for wound and edema complications.

“We will follow these modifications during robotic resection of the inguinal nodes. Nodes, both superficial and deep, can be approached in this fashion and both sides can be performed safely during one setting,” he says. He notes that laparoscopic access is obtained with the use of a spacemaker balloon. Once space is created, the robotic ports are placed, as shown below. The robot is placed in a “side dock” configuration on each side.

Advertisement

A closer look of the inguinal lymph node dissection.

Once in the space, the classic “split and roll” technique is used with the robotic instruments. Anatomic landmarks are used to aid in the dissection. Multiple small, medium and large clips can be used through the assistant port for control of lymphatic channels and small vessels.

Alternatively, a robotic vessel sealer can be used. A multi-use laparoscopic bag is used to collect and retrieve lymph node packets as they are liberated from the region. Once the robot is undocked, careful attention is given to wrapping the thighs tightly to prevent postoperative lymphoceles. This can be transitioned to compression stockings in the future. Patients are instructed to ambulate within the first 24 hours.

Improving patient care

Dr. Krishnan has been incorporating this technique into his practice for the last six years, after completing an advanced urological robotic and laparoscopic fellowship training at Cleveland Clinic.

“Ultimately, our goal is to minimize pain and expedite recovery for patients. A robotic approach to inguinal node dissection has really contributed to these improved outcomes,” he says. “The future of this operation will, undoubtedly, be through the use of the robotic platform.”

Advertisement

Related Articles

Silhouettes of man and woman
February 7, 2025/Cancer/News & Insight
Pharmacokinetics of Many Anticancer Drugs Differ Among Sexes

Slower drug elimination from the body among females may impact safety and efficacy

Mobile mammography van
February 6, 2025/Cancer/News & Insight
Increasing Breast Cancer Screening in Women Experiencing Homelessness

Partnerships with local social service agencies key to program success

Eye melanoma
February 4, 2025/Cancer
Novel Neoadjuvant Treatment Trial for Uveal Melanoma

Oral medication may have potential to preserve vision and shrink tumors prior to surgery or radiation

Specialty pharmacy
January 24, 2025/Cancer/News & Insight
Researchers Seek Actionable Ways to Reduce Time to Treatment of Multiple Myeloma

Study examines modifiable determinants of health disparities

Woman wearing pink scarf
January 17, 2025/Cancer/News & Insight
Exceptional Responders to Metastatic Breast Cancer Treatment Characterized

Findings may guide future research and personalized treatments

Tumor-Infiltrating Lymphocytes (TIL) therapy
January 6, 2025/Cancer/News & Insight
Tumor-Infiltrating Lymphocytes Therapy Now Available for Treating Unresectable or Metastatic Melanoma

Cleveland Clinic Cancer Institute among select group of centers to administer highly personalized treatment

Woman with breast cancer
January 2, 2025/Cancer/News & Insight
Real-World Insights of KEYNOTE-522 Regimen Adoption for Treating Triple-Negative Breast Cancer

Real-world results reporting aims to make treatments safer and more effective

DNA strand
December 31, 2024/Cancer/News & Insight
New Data Further Support Breast Cancer Polygenic Risk Score

Ongoing clinical validation in diverse populations refine breast cancer risk substratification

Ad